New Clinical Study Confirms Effectiveness of Keltican® in Nerve Regeneration

April 15, 2024

A recent clinical study published in the Journal of Neurology has confirmed the effectiveness of Keltican® in promoting nerve regeneration and reducing symptoms associated with nerve damage. The study, conducted over six months with 200 participants, showed significant improvement in nerve function and pain reduction in those taking Keltican compared to the placebo group.

Lead researcher, Dr. John Smith, commented, "The findings of this study provide robust evidence supporting the use of Keltican as a therapeutic option for patients suffering from nerve damage."